The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A.beta. in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A.beta. and antibodies binding to the same.

 
Web www.patentalert.com

< Antibodies against CCR5 and uses thereof

> EphB receptor-binding peptides

> Gene regulation in transgenic animals using a transposon-based vector

~ 00539